192 related articles for article (PubMed ID: 26191372)
1. Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents.
Tang J; Wang B; Wu T; Wan J; Tu Z; Njire M; Wan B; Franzblauc SG; Zhang T; Lu X; Ding K
ACS Med Chem Lett; 2015 Jul; 6(7):814-8. PubMed ID: 26191372
[TBL] [Abstract][Full Text] [Related]
2. Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity.
Lu X; Tang J; Cui S; Wan B; Franzblauc SG; Zhang T; Zhang X; Ding K
Eur J Med Chem; 2017 Jan; 125():41-48. PubMed ID: 27654393
[TBL] [Abstract][Full Text] [Related]
3. Identification of Pyrazolo[1,5-
Hu X; Wan B; Liu Y; Shen J; Franzblau SG; Zhang T; Ding K; Lu X
ACS Med Chem Lett; 2019 Mar; 10(3):295-299. PubMed ID: 30891129
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
[TBL] [Abstract][Full Text] [Related]
6. Identification of
Wu Z; Lu Y; Li L; Zhao R; Wang B; Lv K; Liu M; You X
ACS Med Chem Lett; 2016 Dec; 7(12):1130-1133. PubMed ID: 27994751
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
8. Identification of
Li L; Lv K; Yang Y; Sun J; Tao Z; Wang A; Wang B; Wang H; Geng Y; Liu M; Guo H; Lu Y
ACS Med Chem Lett; 2018 Jul; 9(7):741-745. PubMed ID: 30034611
[TBL] [Abstract][Full Text] [Related]
9. Advancement of Imidazo[1,2-
Moraski GC; Markley LD; Cramer J; Hipskind PA; Boshoff H; Bailey M; Alling T; Ollinger J; Parish T; Miller MJ
ACS Med Chem Lett; 2013 Jul; 4(7):675-679. PubMed ID: 23930153
[TBL] [Abstract][Full Text] [Related]
10. Discovery of new chemical entities as potential leads against Mycobacterium tuberculosis.
Lu X; Tang J; Liu Z; Li M; Zhang T; Zhang X; Ding K
Bioorg Med Chem Lett; 2016 Dec; 26(24):5916-5919. PubMed ID: 27839917
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents.
Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y
Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836
[TBL] [Abstract][Full Text] [Related]
12. Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.
Lv K; You X; Wang B; Wei Z; Chai Y; Wang B; Wang A; Huang G; Liu M; Lu Y
ACS Med Chem Lett; 2017 Jun; 8(6):636-641. PubMed ID: 28626525
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and antitubercular activity of novel N-(amino)piperazinyl benzothiazinones with improved safety.
Wang A; Du N; Song H; Zhang Y; Zhong X; Wu J; Xue T; Liu M; Wang B; Lv K; Lu Y
Eur J Med Chem; 2023 Oct; 258():115545. PubMed ID: 37300914
[TBL] [Abstract][Full Text] [Related]
14. Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors.
Patel H; Jadhav H; Ansari I; Pawara R; Surana S
Eur J Med Chem; 2019 Apr; 167():1-9. PubMed ID: 30743094
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
16. Development of antimycobacterial tetrahydrothieno[2,3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead.
Nallangi R; Samala G; Sridevi JP; Yogeeswari P; Sriram D
Eur J Med Chem; 2014 Apr; 76():110-7. PubMed ID: 24583350
[TBL] [Abstract][Full Text] [Related]
17.
Heinrichs MT; May RJ; Heider F; Reimers T; B Sy SK; Peloquin CA; Derendorf H
Int J Mycobacteriol; 2018; 7(2):156-161. PubMed ID: 29900893
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
Wang A; Wang H; Geng Y; Fu L; Gu J; Wang B; Lv K; Liu M; Tao Z; Ma C; Lu Y
Bioorg Med Chem; 2019 Mar; 27(5):813-821. PubMed ID: 30692025
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antimycobacterial activity of 3,5-dinitrobenzamide derivatives containing fused ring moieties.
Wang A; Huang G; Wang B; Lv K; Wang H; Tao Z; Liu M; Guo H; Lu Y
Bioorg Med Chem Lett; 2018 Sep; 28(17):2945-2948. PubMed ID: 30006066
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
